期刊文献+

帕金森病患者脑干听觉诱发电位与视觉诱发电位测定 被引量:4

Determination of BAEP and VEP in patients with Parkinson disease
下载PDF
导出
摘要 目的研究帕金森病(PD)患者是否存在脑干听觉传导通路与视觉传导通路的损害。方法应用意大利产Reporter型-4通道诱发电位仪对PD患者(男20例,女12例)、非帕金森病患者(对照组,男19例,女11例)进行脑干听觉诱发电位(BAEPⅠ、Ⅲ、Ⅴ峰潜伏期(PL)及Ⅰ-Ⅲ、Ⅲ-Ⅴ、Ⅰ-Ⅴ峰间潜伏期(IPL))、视觉诱发电位(VEPP100PL)检测。结果PD患者BAEP异常率为50%,其中ⅢPL异常率为22%,ⅤPL异常率为19%;ⅢPL为(3.87±0.30)ms,ⅤPL为(5.79±0.30)ms。Ⅲ-Ⅴ>Ⅰ-Ⅲ为31%;与对照组比较(ⅢPL(3.56±0.22)ms,ⅤPL(5.48±0.26)ms)差异有统计学意义(t=5.83,5.85;P<0.01)。PD患者P100PL为(105.17±12.42)ms,对照组为(98.62±9.46)ms,2者相比差异有统计学意义(t=2.49,P<0.05)。结论帕金森病患者除存在黑质-纹状体病变外,可能还存在脑干听觉传导通路与视觉传导通路的损害;听觉诱发电位与视觉诱发电位可作为临床评价帕金森病的客观指标。 Aim: To study whether brain stem auditory and visual passageway are impaired in patients with Parkinson disease(PD). Methods: A total of 32 patients with PD and 30 patients with non-neurological disease were selected, The Reporter type-4 channels evoked potential machine (Italy) was used to check brainstem auditory evoked potential(BAEP) and visual evoked potential(VEP). Indexes of BAEP including peak latency(PL) of wavesⅠ、Ⅲ、Ⅴ and inter-peak latency (IPL) of waves Ⅰ-Ⅲ、Ⅲ-Ⅴ、Ⅰ-Ⅴ and the indexes of VEP (P100PL) were determined. Results:BAEP: the abnormal rate of the PD patients was 50%. PL of wave Ⅲ and wave V was 22% and 19% , respectively. The wave Ⅲ PL ( (3.87 ± 0.30) ms) and wave V PL ( (5.79 ± 0.30) ms) of the PD patients were different from those in the control group ((3.56±0.22) ms, (5.48±0.26) ms,t=5.83,5.85, P 〈 0.01). VEP: the P100PLofthePD patients was higher than that in the control group ( (105.17 ± 12.42) ms, (98.62 ±9.46) ms,t =2.49, P 〈 0.05). Conclusion: There are brain stem auditory and visual pathway impairment in PD patients except for substantianigra-striatum lesion. BAEP and VEP can be taken as sensitive and objective indicators for clinical evaluation of PD.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2007年第3期558-560,共3页 Journal of Zhengzhou University(Medical Sciences)
关键词 帕金森病 脑干听觉诱发电位 视觉诱发电位 Parkinson disease brainstem auditory evoked potential visual evoked potential
  • 相关文献

参考文献16

  • 1陈日坚.帕金森病的诱发电位研究[J].临床脑电学杂志,1999,8(1):55-57. 被引量:3
  • 2Bezard E,Brotchie JM,Gross CE.Pathophysiology of levodopa-induced dyskinesia:potential for new therapies[J].Nat Rev Neurosci,2001,2 (8):577 被引量:1
  • 3闫卫红,程焱,高硕,蔡莉,李彦生,李大成,邢喜玲.轻型帕金森病D_2受体的PET显像[J].中华神经科杂志,2006,39(6):374-378. 被引量:5
  • 4张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 5Parkinson J.An essay on the shaking palsy.1817[J].J Neuropsychiatry Clin Neurosci,2002,14 (2):223 被引量:1
  • 6Adler CH.Nonmotor complications in Parkinson's disease[J].Mov Disord,2005,20 (Suppl 11):s23 被引量:1
  • 7Braak H,Muller CM,Rub U,et al.Pathology associated with sporadic Parkinson's disease--where does it end[J].J Neural Transm Suppl,2006(70):89 被引量:1
  • 8Wacker JL,Zareie MH,Fong H,et al.Hsp70 and Hso70 attenuate formation of spherical and annular polyglutamine oligomers by partitionging monomer[J].Nat Struct Mol Biol,2004,11(12):1 215 被引量:1
  • 9Perez RG,Waymire JC,Lin E,et al.A role for α-synuclein in the regulation of dopamine biosynthesis[J].J Neurosci,2002,22(8):3 090 被引量:1
  • 10Nagatsu T,Ichinose H.Molecular biology of catecholaminerelated enzymes in relation to Parkinson's disease[J].Cell Mol Neurobiol,1999,19 (1):57 被引量:1

二级参考文献37

  • 1王新德.帕金森病及帕金森综合征的诊断标准和鉴别诊断[J].中华神经精神科杂志,1985,18(4):256-256. 被引量:123
  • 2胡昌恒 袁光固 等.帕金森病的神经心理学研究[J].中华神经精神科杂志,1985,18:219-219. 被引量:17
  • 3王新德.帕金森病和帕金森综合征的诊断标准和鉴别诊断[J].中华神经精神科杂志,1985,18(4):256-256. 被引量:19
  • 4中华医学会老年医学学会.中华医学会老年医学学会对健康老年人标准的建议(修订草案,1995年)[J].中华老年医学杂志,1996,15:9-9. 被引量:14
  • 5Erwan B,Sandra D,Caroline P,et al.Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1 -methyl-4-phenyl-1,2,3,6 -tetrahydropyridine-lesioned macaque model of Parkinson's disease.J Neurosci,2001,21:6853-6861. 被引量:1
  • 6Calne DB,Snow BJ,Lee C.Criteria for diagnosing Parkinson's disease.Ann Neurol,1992,32 Suppl:125-127. 被引量:1
  • 7Gelb GJ,Oliver E,Gilman S.Diagnostic criteria for Parkinson's disease.Arch Neurol,1999,56:33-39. 被引量:1
  • 8Gibb WRG.The neuropathology of Parkinson's disease.In:Jankovic J,Tolosa E,eds.Parkinson's disease and movement disorders.Baltimore:Urban and Schwarzenberg,1988.205-223. 被引量:1
  • 9Koller WC.How accurately can Parkinson's disease be diagnosed?Neurology,1992,42Suppl 1:6-16. 被引量:1
  • 10Paulson HL,Stern M.Clinical Manifestations of Parkinson's disease.In:Watts RL,Koller WC,eds.Movement disorders.New York:McGraw-Hill,2004.233-245. 被引量:1

共引文献634

同被引文献42

  • 1黄华品,车春晖,郑安,江芳,庄晓芸,刘楠.帕金森病早期多种诱发电位检测的临床诊断价值[J].中华神经医学杂志,2004,3(5):356-358. 被引量:9
  • 2杨志勇,鲍远程,范红斌,李英,邱丽颖.帕金森病患者正中神经和胫神经体感诱发电位研究[J].现代电生理学杂志,2006,13(2):67-69. 被引量:8
  • 3张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 4Probst A.Bloch A. Tolnay M. New insights into the pathology of Parkinson s disease: does the peripheral autonomic system become central[J]. EurJ Neurol , 2008 .15(Suppl 1) : 1-4. 被引量:1
  • 5Schapira AH. Treatment options in the modern management of Parkinson's disease]]]. Arch Neurol , 2007.64: 1083-1088. 被引量:1
  • 6Schapira AH.Olanow CWo Drug selection and timing of initia?tion of treatment in early Parkinson's disease[J]. Ann Neurol , 2008.64(Suppl 2) :S47-S55. 被引量:1
  • 7Schapira AH,Emre MvJenner P. et al. Levodopa in the treat?ment of Parkinson's disease[1J. EurJ Neurol , 2009.16: 982- 989. 被引量:1
  • 8Mylne AQ.Griffiths C.Rooney Cv et al. Trends in Parkinson's disease related mortality in England and Wales 1993-2006[J]. EurJ Neuro\'2009.16:1010-1016. 被引量:1
  • 9Haberfeld E. Louis ED. Is Parkinson's disease-related mortali?ty declining]"]]. EurJ Neuro\,2009.16:964-965. 被引量:1
  • 10Zhao YJ Tan LC. Lau PN. et al. Factors affecting health-relat?ed quality of life amongst Asian patients with Parkinson' s dis?easc] l]. EurJ Neurol.2008.15: 737-742. 被引量:1

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部